Surveillance, Epidemiology and End Results (SEER) Program - Wayne State

监测、流行病学和最终结果 (SEER) 计划 - 韦恩州立大学

• 批准号: 7657662
• 金额: $ 460.33万
• 依托单位: WAYNE STATE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7657662
• 关键词: Surveillance; Epidemiology; End; Results; SEER

The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 26 percent of the US population. SEER coverage includes 23 percent of African Americans, 40 percent of Hispanic Americans, 42 percent of American Indians and Alaska Natives, 53 percent of Asians, and 70 percent of Hawaiian and Pacific Island Americans. The current SEER data maintained at NCI includes records on 5.4 million cancers. The database serves as important resource for reporting on the burden of cancer, and is utilized by researchers both within and outside of NCI for the purpose of conducting descriptive epidemiologic studies. The SEER Program is a core component of the NCI's surveillance activities which provide information used for planning cancer control and research programs, and for evaluating the impact of such programs on cancer rates. The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. The SEER Program has among its objectives: 1. To assemble and report, on a periodic basis, estimates of cancer incidence. 2. To monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. 3. To provide continuing information on changes over time in extent of disease at diagnosis, trends in therapy, and changes in cancer patient survival. 4. To identify the occurrence of possible iatrogenic cancers, i.e., cancers that are caused by cancer therapy. 5. To serve as a research resource to the National Cancer Institute, and conduct studies dealing with current cancer control issues as well as problems related to the operation of the SEER Program.

国家癌症研究所（NCI）的监视，流行病学和最终结果（SEER）计划是美国癌症发病率和生存的权威来源。 SEER目前从基于人群的癌症登记处收集并发布了癌症的发病率和生存数据，占美国人口的约26％。先知覆盖范围包括23％的非洲裔美国人，40％的西班牙裔美国人，42％的美国印第安人和阿拉斯加原住民，53％的亚洲人以及70％的夏威夷和太平洋岛上的美国人。 NCI维护的当前的SEER数据包括540万次癌症的记录。该数据库是报告癌症负担的重要资源，并被NCI内外的研究人员用于进行描述性流行病学研究。 SEER计划是NCI监视活动的核心组成部分，该活动提供了用于计划癌症控制和研究计划的信息，并评估了此类计划对癌症率的影响。 SEER计划于1972年启动，以应对国家癌症计划的要求，以评估美国癌症负担的大小，并确定与癌症风险和/或患者生存有关的因素。 SEER计划具有其目标： 1。要定期组装和报告癌症发病率的估计。 2。监测年度癌症发病率趋势，以确定由地理，人口统计学和社会特征定义的人群亚组发生的特定癌症的异常变化。 3。提供有关随着时间的变化的持续信息，诊断趋势，治疗趋势以​​及癌症患者生存的变化。 4。确定可能的医源性癌症的发生，即是由癌症治疗引起的癌症。 5。作为国家癌症研究所的研究资源，并进行有关当前癌症控制问题的研究以及与SEER计划有关的问题。